Galectin Therapeutics Revenue 2006-2019 | GALT

Galectin Therapeutics revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Galectin Therapeutics Annual Revenue
(Millions of US $)
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
2008 $
2007 $
2006 $
2005 $
Galectin Therapeutics Quarterly Revenue
(Millions of US $)
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q3 2011
Q2 2011
Q1 2011
Q4 2010
Q3 2010
Q2 2010
Q1 2010
Q4 2009
Q3 2009
Q2 2009
Q1 2009
Q4 2008
Q3 2008
Q2 2008
Q1 2008
Q4 2007
Q3 2007
Q2 2007
Q1 2007
Q4 2006
Q3 2006
Q2 2006
Q1 2006
Q4 2005
Q3 2005
Q2 2005
Q1 2005
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.178B $0.000B
Galectin Therapeutics Inc. is a drug development company engaged in the development new therapies for fibrotic disease and cancer. The Company uses its carbohydrate technology that targets galectin proteins, the key mediators of biologic and pathologic function. Galectin Therapeutics uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. Galectin Therapeutics, formerly known as Pro-Pharmaceuticals, Inc. is headquartered in Newton, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.318B 34.70
Astellas Pharma (ALPMY) Japan $28.136B 13.80
Takeda Pharmaceutical (TAK) Japan $27.904B 8.19
UCB SA (UCBJF) Belgium $15.866B 0.00
Eisai (ESALY) Japan $15.830B 27.22
Grifols, S.A (GRFS) Spain $15.051B 19.03
Merck (MKGAF) Germany $13.273B 18.11
IPSEN SA ADR (IPSEY) France $10.783B 0.00
Ionis Pharmaceuticals (IONS) United States $9.487B 20.74
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Sage Therapeutics (SAGE) United States $9.220B 0.00
Neurocrine Biosciences (NBIX) United States $7.950B 0.00
Catalent (CTLT) United States $7.831B 31.43
Jazz Pharmaceuticals (JAZZ) Ireland $7.737B 10.61
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Nektar Therapeutics (NKTR) United States $5.663B 9.23
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 24.34
Hypermarcas (HYPMY) Brazil $4.786B 16.82
Tilray (TLRY) Canada $4.318B 0.00
Evotec AG (EVTCY) Germany $4.265B 45.78
FibroGen (FGEN) United States $4.003B 0.00
United Therapeutics (UTHR) United States $3.326B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.177B 11.40
Arrowhead Pharmaceuticals (ARWR) United States $2.670B 402.29
Xencor (XNCR) United States $2.517B 68.71
PTC Therapeutics (PTCT) United States $2.512B 0.00
Zogenix (ZGNX) United States $2.004B 0.00
Portola Pharmaceuticals (PTLA) United States $1.749B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.689B 81.82
Ironwood Pharmaceuticals (IRWD) United States $1.614B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.604B 21.92
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Heron Therapeutics (HRTX) United States $1.482B 0.00
USANA Health Sciences (USNA) United States $1.446B 12.57
Corcept Therapeutics (CORT) United States $1.231B 17.57
ArQule (ARQL) United States $1.164B 0.00
Aerie Pharmaceuticals (AERI) United States $1.119B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.014B 0.00
Radius Health (RDUS) United States $1.010B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.977B 3.52
Spectrum Pharmaceuticals (SPPI) United States $0.880B 0.00
Endo (ENDP) Ireland $0.835B 1.34
Concordia (CXRXF) Canada $0.719B 0.00
Aptorum Group (APM) China $0.652B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.594B 0.00
TherapeuticsMD (TXMD) United States $0.591B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.584B 0.00
Organogenesis Holdings (ORGO) United States $0.576B 0.00
GlycoMimetics (GLYC) United States $0.549B 0.00
Translate Bio (TBIO) United States $0.495B 0.00
Karyopharm Therapeutics (KPTI) United States $0.481B 0.00
ChemoCentryx (CCXI) United States $0.480B 0.00
Akebia Therapeutics (AKBA) United States $0.477B 0.00
Dermira (DERM) United States $0.465B 0.00
Siga Technologies (SIGA) United States $0.461B 1.09
BioSpecifics Technologies Corp (BSTC) United States $0.458B 23.12
Dova Pharmaceuticals (DOVA) United States $0.454B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.422B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.418B 0.00
CV Sciences (CVSI) United States $0.417B 0.00
Flexion Therapeutics (FLXN) United States $0.415B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.410B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.409B 0.00
Indivior (INVVY) United States $0.401B 1.45
BioCryst Pharmaceuticals (BCRX) United States $0.393B 0.00
CannTrust Holdings (CTST) Canada $0.388B 0.00
Innate Pharma SA (IPHYF) France $0.369B 0.00
Harpoon Therapeutics (HARP) United States $0.366B 0.00
Collegium Pharmaceutical (COLL) United States $0.362B 0.00
ImmunoGen (IMGN) United States $0.341B 0.00
Xeris Pharmaceuticals (XERS) United States $0.333B 0.00
KalVista Pharmaceuticals (KALV) United States $0.297B 0.00
OptiNose (OPTN) United States $0.291B 0.00
Rafael Holdings (RFL) United States $0.287B 0.00
Molecular Templates (MTEM) United States $0.276B 0.00
Concert Pharmaceuticals (CNCE) United States $0.263B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.243B 0.00
Aratana Therapeutics (PETX) United States $0.241B 0.00
Lannett Co Inc (LCI) United States $0.227B 2.20
Ocular Therapeutix (OCUL) United States $0.222B 0.00
Recro Pharma (REPH) United States $0.221B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.220B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.215B 0.00
Redhill Biopharma (RDHL) Israel $0.184B 0.00
Calithera Biosciences (CALA) United States $0.171B 0.00
Nature's Sunshine Products (NATR) United States $0.170B 55.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.168B 0.00
IMV INC (IMV) Canada $0.166B 0.00
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
Ardelyx (ARDX) United States $0.162B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
Jounce Therapeutics (JNCE) United States $0.142B 0.00
Majesco Entertainment (PTE) United States $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.128B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.124B 0.00
AgeX Therapeutics (AGE) United States $0.120B 0.00
DURECT (DRRX) United States $0.112B 0.00
Aquestive Therapeutics (AQST) United States $0.107B 0.00
Generex Biotechnology (GNBT) United States $0.099B 0.00
RENEURON GP (RNUGF) United Kingdom $0.094B 0.00
Infinity Pharmaceuticals (INFI) United States $0.094B 0.00
Genocea Biosciences (GNCA) United States $0.092B 0.00
Aclaris Therapeutics (ACRS) United States $0.091B 0.00
Mast Therapeutics (SVRA) United States $0.091B 0.00
Iterum Therapeutics (ITRM) Ireland $0.091B 0.00
Capnia (SLNO) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.089B 63.33
Avadel Pharmaceuticals (AVDL) Ireland $0.087B 0.00
MediWound (MDWD) Israel $0.087B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Cardiome Pharma (CORV) Canada $0.084B 0.00
Natural Alternatives (NAII) United States $0.082B 8.23
China SXT Pharmaceuticals (SXTC) China $0.080B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.080B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Nivalis Therapeutics (ALPN) United States $0.076B 0.00
Novan (NOVN) United States $0.075B 0.00
Pharmaxis (PXSLY) Australia $0.071B 0.00
Neos Therapeutics (NEOS) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.061B 0.00
India Globalization Capital (IGC) United States $0.060B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00